French clinicians involved in weaning myasthenic patients undergoing decompensation (myasthenic crisis) report the results of the WEAN Safe protocol applied to a single-center cohort (Paris, Salpêtrière):
- of the 698 admissions to intensive care for this reason, only the records of 81 patients covering the period 2008-2023 were selected for the study,
- the median age of patients was 70 years, with a higher proportion of men, two-thirds of whom were cases of very late-onset myasthenia gravis (> 65 years),
- according to the WEAN Safe classification, 3% of patients had rapid weaning, 40% had medium-term weaning, 55% experienced prolonged weaning, and 3% could not be weaned.
- The late onset of myasthenia gravis did not influence the results.
- However, the presence of thymoma and/or the absence of prior immunosuppressive treatment were associated with a poorer prognosis.